Achieving the national health objective for influenza immunization: success of an institution-wide vaccination program.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 2382664)

Published in Am J Med on August 01, 1990

Authors

K L Nichol1, J E Korn, K L Margolis, G A Poland, R A Petzel, R P Lofgren

Author Affiliations

1: Department of Medicine, Veterans Affairs Medical Center, Minneapolis, Minnesota 55417.

Articles by these authors

The effectiveness of vaccination against influenza in healthy, working adults. N Engl J Med (1995) 6.16

Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med (1993) 6.09

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med (1994) 5.38

Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med (2000) 4.11

Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA (1990) 3.71

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78

Resident research in internal medicine training programs. Ann Intern Med (1996) 2.77

Vetting medical school applicants on basis of potential hepatitis B transmission. Lancet (1994) 2.71

Accuracy of self-report of mammography and Pap smear in a low-income urban population. Am J Prev Med (1998) 2.15

Why do patients of female physicians have higher rates of breast and cervical cancer screening? J Gen Intern Med (1997) 1.93

Twin studies of immunogenicity--determining the genetic contribution to vaccine failure. Vaccine (2001) 1.88

Live attenuated measles virus induces regression of human lymphoma xenografts in immunodeficient mice. Blood (2001) 1.82

Influenza vaccination. Knowledge, attitudes, and behavior among high-risk outpatients. Arch Intern Med (1992) 1.70

Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol (1979) 1.64

Chylothorax in Gorham's syndrome. A common complication of a rare disease. Chest (1994) 1.62

Effects of a night float system on housestaff neuropsychologic function. J Gen Intern Med (1993) 1.50

Use of influenza and pneumococcal vaccines in people with diabetes. Diabetes Care (2000) 1.49

Preoperative screening: value of previous tests. Ann Intern Med (1990) 1.48

Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study. Ann Intern Med (1989) 1.46

Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine. J Infect Dis (1999) 1.45

Early measles virus infection is associated with the development of inflammatory bowel disease. Am J Gastroenterol (2000) 1.42

Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial. Arch Intern Med (1996) 1.42

Adult immunizations: recommendations for practice. Mayo Clin Proc (1999) 1.40

Understanding racial variation in the use of coronary revascularization procedures: the role of clinical factors. Arch Intern Med (2000) 1.40

Emergence of ciprofloxacin resistance in nosocomial methicillin-resistant Staphylococcus aureus isolates. Resistance during ciprofloxacin plus rifampin therapy for methicillin-resistant S aureus colonization. Arch Intern Med (1990) 1.39

Tuberculin skin testing in medical students: a survey of U.S. medical schools. Ann Intern Med (1994) 1.39

Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology (2009) 1.32

Making vaccines more acceptable--methods to prevent and minimize pain and other common adverse events associated with vaccines. Vaccine (2001) 1.32

Estimation of outpatient risk characteristics and influenza vaccination status: validation of a self-administered questionnaire. Am J Prev Med (1992) 1.31

Associations between cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens (2008) 1.26

Hospital-based versus community-based clinical education: comparing performances and course evaluations by students in their second-year pediatrics rotation. Acad Med (1993) 1.20

Improving cancer incidence estimates for American Indians in Minnesota. Am J Public Health (1999) 1.18

Secondary failure rates of measles vaccines: a metaanalysis of published studies. Pediatr Infect Dis J (1996) 1.15

A randomized community trial to increase mammography utilization among low-income women living in public housing. Prev Med (1999) 1.15

Effect of a change in house staff work schedule on resource utilization and patient care. Arch Intern Med (1991) 1.14

Teaching status and resource use for patients with acute myocardial infarction: a new look at the indirect costs of graduate medical education. Am J Public Health (1990) 1.13

Adult immunization. Prim Care (1989) 1.13

Screening for problem drinking: impact on physician behavior and patient drinking habits. J Gen Intern Med (1998) 1.09

Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin Exp Immunol (2005) 1.07

The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun (2011) 1.06

Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma-secreting T cells. Scand J Clin Lab Invest (2005) 1.05

Utility of a "swish and spit" technique for the collection of buccal cells for TAP haplotype determination. Mayo Clin Proc (1995) 1.04

Pharmacology, vaccinomics, and the second golden age of vaccinology. Clin Pharmacol Ther (2007) 1.03

Childhood asthma and human leukocyte antigen type. Tissue Antigens (2007) 1.00

Mass spectrometry and peptide-based vaccine development. Clin Pharmacol Ther (2007) 0.98

Vaccine safety: injecting a dose of common sense. Mayo Clin Proc (2000) 0.98

Parameters potentially affecting interpretation of immunogenicity and efficacy data in vaccine trials: are they adequately reported? Vaccine (1996) 0.97

Gene expression microarrays: a 21st century tool for directed vaccine design. Vaccine (2001) 0.97

Adult immunizations. Ann Intern Med (1996) 0.97

Prosthetic valve endocarditis due to Achromobacter xylosoxidans. Am Heart J (1981) 0.96

Neurofibromatosis with involvement of the prostate gland. Urology (1996) 0.96

Comparing students' feedback about clinical instruction with their performances. Acad Med (1991) 0.95

Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes Immun (2013) 0.94

Effectiveness of influenza vaccine in the elderly. Gerontology (1996) 0.92

Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response. Vaccine (1999) 0.92

A comparative trial of standard or high-dose S subunit recombinant hepatitis B vaccine versus a vaccine containing S subunit, pre-S1, and pre-S2 particles for revaccination of healthy adult nonresponders. J Infect Dis (1997) 0.90

Frequency of adverse reactions after influenza vaccination. Am J Med (1990) 0.90

An internist joins the surgery service: does comanagement make a difference? J Gen Intern Med (1994) 0.90

Induction of CD4 T cell proliferation and in vitro Th1-like cytokine responses to measles virus. Clin Exp Immunol (2005) 0.89

Women's preferences for specialists who provide cancer screening and general medical care. J Gen Intern Med (1998) 0.89

Beneficial effects of treatment of nicotine dependence during an inpatient substance abuse treatment program. JAMA (1990) 0.89

Outpatient internal medicine preoperative evaluation: a randomized clinical trial. Med Care (1994) 0.89

Measuring mammography compliance: lessons learned from a survival analysis of screening behavior. Cancer Epidemiol Biomarkers Prev (1998) 0.89

Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee. Pediatrics (1999) 0.89

The genetic basis for measles vaccine failure. Acta Paediatr Suppl (2004) 0.89

Outbreak of parasitic gastroenteritis among travelers returning from Africa. Arch Intern Med (1985) 0.89

A randomized, controlled study in adults of the immunogenicity of a novel hepatitis B vaccine containing MF59 adjuvant. Vaccine (1999) 0.88

Linkage relationship of C2 deficiency, HLA and glyoxalase I loci. Vox Sang (1979) 0.88

The impact of a simulated immunization registry on perceived childhood immunization status. Am J Manag Care (1998) 0.87

Correlations between measles, mumps, and rubella serum antibody levels in Olmsted County school children. Vaccine (2001) 0.87

Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. Vaccine (2001) 0.87

Questionable data and preconceptions: reconsidering the value of mammography for American Indian Women. Am J Public Health (1997) 0.86

Appropriateness of imaging procedure requests: do radiologists agree? AJR Am J Roentgenol (1997) 0.86

Organizational strategies to improve influenza vaccine delivery. A standing order in a general medicine clinic. Arch Intern Med (1988) 0.85

Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int J Infect Dis (1998) 0.84

A noninvasive 'swish and spit' method for collecting nucleated cells for HLA typing by PCR in population studies. Hum Hered (1996) 0.84

Acceptance of hepatitis B vaccine by hospital personnel. Infect Control (1985) 0.83

Crescentic glomerulonephritis and renal failure associated with malignant lymphoma. Am J Clin Pathol (1979) 0.83

Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer (2008) 0.83

Medical technologists using molecular epidemiology as part of the infection control team. Diagn Microbiol Infect Dis (1993) 0.82

Low-resolution structure of the complex of human blood platelet factor 4 with heparin determined by small-angle neutron scattering. Biochim Biophys Acta (1986) 0.82

The influence of the HLA-DRB1*13 allele on measles vaccine response. J Investig Med (1996) 0.81

Implementation and evaluation of a faculty development program to improve clinical teaching. J Med Educ (1980) 0.81

Deciding to restrain medical patients. J Am Geriatr Soc (1990) 0.81

Isolation and rapid identification of an abundant self-peptide from class II HLA-DRB1*0401 alleles induced by measles vaccine virus infection. J Immunol Methods (2000) 0.81

Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus. Vaccine (1997) 0.81

The dynamic nature of sensitivity and specificity. J Gen Intern Med (1988) 0.81

Acute oligoarthritis associated with Clostridium difficile pseudomembranous colitis. Arch Intern Med (1984) 0.80

Evaluation of a program by assessing students' performance at the beginning of the next course. J Med Educ (1978) 0.80

The pneumococcal conjugate vaccine. Minerva Pediatr (2002) 0.79

Scatter analysis of discrete-sized chromatin fragments favours a cylindrical organization. Eur J Biochem (1985) 0.79

Senior medical students as simulated patients in an objective structured clinical examination: motivation and benefits. Med Teach (1992) 0.78

An assessment of the association between childhood asthma and HLA DRB1*03 using extended haplotype analysis. Tissue Antigens (2010) 0.78

White blood cell telomerase activity and incident respiratory illness among community-dwelling elderly vaccinated against seasonal influenza. Clin Pharmacol Ther (2007) 0.78

Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review. Biomed Pharmacother (2000) 0.78

The surprisingly high acceptability of low-efficacy vaccines for otitis media: a survey of parents using hypothetical scenarios. Pediatrics (1995) 0.78

Intranasal influenza vaccine: adding to the armamentarium for influenza control. JAMA (1999) 0.78